April 8th 2025
The new data builds upon previously reported 6- and 12-month positive results from adult patients treated in the same study.
Eye Care Symposia in Los Angeles
April 25-26, 2025
Register Now!
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (CME Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (CME Track)
View More
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics (COPE Track)
View More
Community Practice Connections™: Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention (COPE Track)
View More
Surv.AI Says: Real-World Insights Into Patient Burden & Evolving Strategies in nAMD and DME (CME Credit)
View More
Surv.AI Says: Real-World Insights into Patient Burden & Evolving Strategies in nAMD and DME (COPE Credit)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (CME Track)
View More
Assessing the Evidence for Extending Treatment Intervals in nAMD and DME Management – Expert Insights into Innovative Approaches (COPE Track)
View More
Community Practice Connections™: Optimizing Outcomes in Glaucoma Management - Applying Evidence to Practice with a Multitude of Treatment Options (COPE Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (CME Track)
View More
Reimagining Dry Eye Disease: Delineating the Role of Evaporation From Inflammation and Insights Into Optimizing Treatment (COPE Track)
View More
19th Annual Controversies in Modern Eye Care
May 4, 2025
Register Now!
(CME Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(COPE Track) Community Practice Connections™: Advancing the Optimal Diagnosis & Treatment of Thyroid Eye Disease
View More
(CME) Community Practice Connections™: A Closer Look at Neurotrophic Keratitis—Ensuring Timely Diagnosis and Taking Early Action
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (CME Track)
View More
Outlining the New Standard in Geographic Atrophy: Optimizing Care Within the Modern Treatment Paradigm (COPE Track)
View More
Collaborative Care Symposium
May 30-31, 2025
Register Now!
Community Practice Connections™: Novel Therapies for Neovascular Retinal Disease – Expert Analysis of New Key Data
View More
Practical Approaches to Modern Dry Eye Treatment and Management
June 25, 2025
Register Now!
Latest Advances in X-Linked Retinitis Pigmentosa: Optimizing Diagnosis and Developments in Gene Therapy
View More
Cases & Conversations™: Real World Review of Treat and Extend Strategies for Neovascular Retinal Disease
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (CME Track)
View More
Community Practice Connections™: Innovations and Interdisciplinary Approaches in Glaucoma Management—Expanding the Treatment Arsenal (COPE Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (CME Track)
View More
Road Mapping the Treat-and-Extend Protocol in nAMD and DME – When Time Is Sight (COPE Track)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (CME Credit)
View More
Community Practice Connections™: Navigating Complexities in Neurotrophic Keratitis — A Roadmap for Advanced Patient Care (COPE Credit)
View More
AAPOS backs pediatric screening
July 15th 2005Orlando—Ongoing efforts to encourage the adoption of mandatory preschool vision screening in every state were the main topic of discussion during a workshop at the annual meeting of the American Academy of Pediatric Ophthalmology and Strabismus (AAPOS).
Read More
Pediatric eye specialist honored at meeting
May 15th 2005Orlando—The American Association for Pediatric Ophthalmology and Strabismus recently honored Leonard Apt, MD, professor of ophthalmology and founding director of the division of pediatric ophthalmology at the Jules Stein Eye Institute at UCLA, at the group's annual meeting here.
Read More
Atropine treatment of moderate amblyopia assessed
April 1st 2005Baltimore—Prescribed weekend atropine sulfate 1% appears to be as effective as prescribed daily use for treating moderate amblyopia in young children, according to results from a study conducted by the Pediatric Eye Disease Investigator Group.
Read More
Transitions offers initiatives for success
March 15th 2005Orlando—Transitions Optical is offering new point-of-sale tools that allow eye-care professionals to add a personal touch to their discussion of healthy vision with patients. More than half of the materials now offered are customizable using the Transitions Online Marketing (TOM) tool.
Read More
J&J increases Definity lenses distribution
March 15th 2005Atlanta—Robertson Optical Laboratories, which operates wholesale lab branches in Georgia and South Carolina, has been selected as one of two wholesale lab companies to be authorized distributors of Definity lenses by manufacturer Johnson & Johnson.
Read More
TTT stabilizes vision in advanced AMD-related CNV
March 15th 2005Coronado, CA—Transpupillary thermotherapy (TTT) alone and combined with a single pretreatment intravitreal injection of triamcinolone acetonide 4 mg are similarly associated with vision stabilization over a 6-month follow-up period in eyes with large complicated choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD), reported Jans Fromow-Guerra, MD, PhD, at the annual meeting of the American Society of Retinal Specialists.
Read More
Corticosteroids may benefit pediatric orbital cellulitis
March 15th 2005Houston—Use of intravenous corticosteroids in the acute management of pediatric orbital cellulitis with subperiosteal abscess did not have an adverse effect on clinical outcomes and may be beneficial, according to Michael T. Yen, MD.
Read More
Allergic disease therapies key to patient quality of life
March 1st 2005Quality of life (QOL) has become an issue in every branch of medicine, including ophthalmology. From an economic perspective, loss of productivity contributes to the economic burden of a disease in the same manner as the shared costs of treatment.
Read More
Children achieve relief of ocular allergies
March 1st 2005Chicago—Ketotifen fumarate 0.025% ophthalmic solution (Zaditor, Novartis) offers rapid-onset, long-lasting relief of allergy-associated itching along with excellent local tolerability and a long-standing record of safety. Those features combined make it an outstanding therapeutic choice for all patients with allergic conjunctivitis and a particularly attractive option for the pediatric population, said Kimberlee M. Curnyn, MD.
Read More
Clinical focus for incontinentia pigmenti requires redirection
December 1st 2004Coronado Island, CA-The focus of attention in caring for babies with incontinentia pigmenti (IP) should be on the potential for rapid development of irreversible blindness rather than on the clinically obvious skin manifestations, said Morton F. Goldberg, MD, in the Gertrude D. Pyron Award Lecture at the annual meeting of the American Society of Retina Specialists.
Read More
Subconjunctival fibrosis one cause of failed glaucoma filter
October 15th 2004New York -Five potential causes of failure of glaucoma filtration surgery include excessive subconjunctival fibrosis, tight scleral flap sutures, encapsulated bleb, occluded internal ostium, and intraocular obstruction, according to James C. Tsai, MD.
Read More
Early diagnosis essential in cerebrovascular dissections
August 15th 2004Philadelphia-Cerebrovascular dissection represents a life-and-death situation for the patient. Ophthalmologists should be able to recognize this potentially catastrophic diagnosis and initiate emergent treatment, said Nicholas Volpe, MD.
Read More
The pediatric eyewear market may be a rewarding and lucrative off-shoot for ophthalmologists who have already chosen to include a dispensary in their practices. Robert S. Gold, MD, of Eye Physicians of Central Florida, Orlando, offers this advice about including pediatric and youth eyewear in a busy ophthalmologic practice.
Read More